Figure 4

![Figure 4: Nanoparticle delivery systems designed to enhance curcumin's pharmacokinetic profile for CNS applications are categorized, including liposomes, polymeric, and lipid nanoparticles.]()

> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)

<figure>
  <img src="" alt="Nanoparticle delivery systems designed to enhance curcumin's pharmacokinetic profile for CNS applications are categorized, including liposomes, polymeric, and lipid nanoparticles." />
  <figcaption>Figure 4. Nanoparticle delivery systems designed to enhance curcumin's pharmacokinetic profile for CNS applications are categorized, including liposomes, polymeric, and lipid nanoparticles.<br>  Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption>
</figure>